Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

77.72 -1.20 (-1.52%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dexcom Inc

< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
S&P 500 Giants Lead Five Stocks Near Buy Points With Fed's Powell A Tailwind
DexCom, Blackstone and Royal Caribbean head this list of five stocks. 
Via Investor's Business Daily
Topics Economy Stocks
Exposures Interest Rates US Equities
NASDAQ:DXCM—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
DEXCOM INC (NASDAQ:DXCM) qualifies as a high growth stock and is consolidating. 
Via Chartmill
DexCom's Options: A Look at What the Big Money is Thinking
Via Benzinga
Edwards Lifesciences Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
The Relative Strength (RS) Rating for Edwards Lifesciences stock jumped into a new percentile Tuesday, with a rise from 78 to 81. 
Via Investor's Business Daily
DexCom Stock Trying To Close In On Key Technical Benchmark
In a welcome move, medical device DexCom stock saw its Relative Strength Rating improve from 68 to 73 on Monday. 
Via Investor's Business Daily
Here's How Much You Would Have Made Owning DexCom Stock In The Last 15 Years
Via Benzinga
Analyst Expectations For DexCom's Future
Via Benzinga
NASDAQ:DXCM qualifies as a high growth stock and is consolidating.
Exploring the Growth Potential of DEXCOM INC (NASDAQ:DXCM) as It Nears a Breakout. 
Via Chartmill
Here's How Much $100 Invested In DexCom 15 Years Ago Would Be Worth Today
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
DexCom Is 'Expanding Rapidly' With Multi-Year Runway Ahead, Bullish Analyst Says
DexCom Inc’s (NASDAQ: DXCM) Stelo Glucose Biosensor System has been approved by the Food and Drug Administration (FDA) as the first over-the-counter (OTC) 
Via Benzinga
Tandem Diabetes Care Stock Belongs On Your Watchlist As RS Rating Jump Higher
On Monday, Tandem Diabetes Care stock received an upgrade to its Relative Strength (RS) Rating, from 68 to 78. 
Via Investor's Business Daily
ServiceNow Setting Up As Three Stocks Flash Buy Signals
All four stocks to watch boast solid earnings growth. 
Via Investor's Business Daily
2 Medical Device Stocks to Buy Hand Over Fist in March
Don't let their modest gains over the past year mislead you; these stocks can make for great long-term investments. 
Via The Motley Fool
Palantir Technologies, SL Green Realty And A Healthcare Stock On CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Jenny Harrington of Gilman Hill Asset Management named SL Green Realty Corp. 
Via Benzinga
FDA Approval For DexCom's Stelo Opens Continuous Glucose Monitoring To Masses, Analyst Expects Competitive Pricing Against Abbott's
FDA greenlights DexCom's Stelo, the first OTC continuous glucose monitor for non-insulin-dependent diabetics. Competitive pricing, potential HSA benefits, and market expansion make it a significant... 
Via Benzinga
Exposures Product Safety
Stocks Surge, Gold Hits New All-Time High, Bitcoin Reclaims $67,000 As Powell Reassures Wall Street: What's Driving Markets Wednesday?
Markets rallied across the board on Wednesday, erasing the uptick in volatility seen in the previous session, following reassurances from Fed Chair Jerome Powell regarding the Fed’s willingness to ease... 
Via Benzinga
Topics Economy
Exposures Interest Rates
Why Dexcom — And The Obesity Market — Could Benefit From This New FDA Win
The FDA granted Dexcom's Stelo a broad clearance, meaning people without diabetes can use it. 
Via Investor's Business Daily
Exposures Product Safety
FDA Approves Dexcom's Stelo As First Glucose Monitoring Device Without Prescription
FDA-approved Dexcom Stelo: Over-the-counter glucose monitoring for non-insulin users. Stelo, the first OTC CGM, available online without prescription from summer 2024. Continuous glucose tracking with... 
Via Benzinga
Exposures Product Safety
Campbell Soup, Box And 3 Stocks To Watch Heading Into Wednesday
With U.S. stock futures trading mostly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Adding $1,000 to These Top Growth Stocks Would Be a Brilliant Move
With patience, these stocks will provide outsized returns to investors. 
Via The Motley Fool
Record-High S&P 500 Propels SPY ETF To $500-Billion Milestone, Nvidia Tops $2 Trillion, Broadcom Surpasses Tesla
U.S. stock market continues bull run, hitting record highs for S&P 500 and Nasdaq 100. SPY ETF surpasses $500 billion AUM, with other companies also reaching milestones. 
Via Benzinga
Topics ETFs Stocks
Exposures US Equities
3 Telehealth Stocks With Room to Run in 2024
Embrace 2024's leading telehealth stocks to buy, merging cutting-edge care with smart investing for a lucrative portfolio. 
Via InvestorPlace
DexCom: A Winner In Diabetes Management
Diabetes management and glucose monitoring solutions provider DexCom, Inc. recently released its fourth-quarter results, reporting $1.0 billion in revenue, up 27% year-over-year compared to $820... 
Via Talk Markets
Got $1,000? Buy These Hot Growth Stocks Before They Take Off
If you have just $1,000 to spare, you can scoop up shares of these growth stocks before their prices explode. 
Via The Motley Fool
Xylem, DexCom And 2 Other Stocks Insiders Are Selling
The Nasdaq 100 closed lower by around 0.4% on Wednesday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution
Obesity drug sales boomed in 2023 and will continue in 2024. That could make these weight loss stocks even more attractive. 
Via InvestorPlace
These 2 Growth Stocks Could Soar 33% and 45% According to Wall Street Analysts. Are They Smart Buys Now?
Expectations are high for companies making blood sugar monitors and business automation software. 
Via The Motley Fool
Wall Street's Next Stock-Split Stocks Are Liable to Be Familiar Names
Nine high-profile stocks -- Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, Monster Beverage, and Novo Nordisk -- have split since mid-2021. Two of these companies appear ready... 
Via The Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
Companies in the healthcare industry tend to generate returns in a wide range of market environments. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.